HMI-202, Investigational Gene Therapy for Metachromatic Leukodystrophy (MLD). HMI-202, Investigational Gene Therapy for Metachromatic Leukodystrophy (MLD). Gingras J, St-Martin T, Gall K, et al. ASHG 2019.